Elevance Health and UnitedHealth Group are scheduled to report their quarterly earnings this week, with analysts closely watching for signs of improved management of rising medical costs. Elevance, which operates Blue Cross and Blue Shield plans in 14 states, and UnitedHealth, the largest health insurer in the U.S. through its UnitedHealthcare division, will be the first major health insurers to release second-quarter results.
Key Details
Both companies are emerging from a period where many insurers reported medical loss ratios exceeding 90% for much of 2025. However, Elevance reported a benefit expense ratio of 86.8% in the first quarter of 2026, reflecting a slight increase but indicating a potential stabilization in costs. Analysts expect that the upcoming earnings reports will show continued control over medical cost trends, particularly in Medicare Advantage plans, which are critical for both companies.
Background
Elevance’s operations include Medicaid coverage for low-income individuals, Medicare Advantage for seniors, and commercial health insurance under the Affordable Care Act. The company's performance in these segments will be pivotal in assessing the overall health insurance market's recovery from elevated medical costs. According to industry analysts, the second-quarter results could provide insights into whether the sector is turning a corner after a challenging period.
Related coverage: Over 2,700 Deaths Linked to UK Heatwaves in May and June.
The earnings reports from Elevance and UnitedHealth could influence healthcare stocks and indices, particularly those focused on health insurance. Positive results may boost investor confidence in the sector, while disappointing figures could lead to downward pressure on shares. Investors will watch for the companies' commentary on cost management and future outlooks during their earnings calls.